See more : Senior Connect Acquisition Corp. I (SNRH) Income Statement Analysis – Financial Results
Complete financial analysis of OneMedNet Corporation (ONMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of OneMedNet Corporation, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
You may be interested
- Immo-Antares NV (ANT.BR) Income Statement Analysis – Financial Results
- PT Victoria Insurance Tbk (VINS.JK) Income Statement Analysis – Financial Results
- Dr. Ing. h.c. F. Porsche AG (DRPRY) Income Statement Analysis – Financial Results
- PT WIR ASIA Tbk (WIRG.JK) Income Statement Analysis – Financial Results
- Bearing Lithium Corp. (BRZ.V) Income Statement Analysis – Financial Results
OneMedNet Corporation (ONMD)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.onemednet.com
About OneMedNet Corporation
OneMedNet Corporation develops technology that focuses on accessing and sharing health data. It offers BEAM Medical Image Exchange & Management Suite, a solution that manages, exchanges, and shares medical images with patients, care providers, and hospitals. The company was founded in 2009 and is based in Eden Prairie, Minnesota with a development office in Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 1.02M | 1.15M | 1.09M | 824.03K |
| Cost of Revenue | 1.15M | 1.51M | 1.21M | 611.66K |
| Gross Profit | -127.90K | -360.69K | -113.41K | 212.37K |
| Gross Profit Ratio | -12.52% | -31.29% | -10.39% | 25.77% |
| Research & Development | 1.63M | 952.70K | 642.77K | 307.27K |
| General & Administrative | 5.27M | 3.45M | 1.20M | 2.06M |
| Selling & Marketing | 1.11M | 957.69K | 605.24K | 318.41K |
| SG&A | 6.61M | 4.40M | 1.80M | 2.38M |
| Other Expenses | 0.00 | -46.82K | -34.91K | -83.00K |
| Operating Expenses | 6.72M | 5.76M | 2.60M | 3.14M |
| Cost & Expenses | 7.87M | 7.27M | 3.80M | 3.76M |
| Interest Income | 0.00 | 0.00 | 0.00 | 193.55K |
| Interest Expense | 749.21K | 403.31K | 195.38K | 0.00 |
| Depreciation & Amortization | 28.00K | 24.81K | 14.47K | 13.92K |
| EBITDA | -22.43M | -5.59M | -2.70M | -2.92M |
| EBITDA Ratio | -2,195.30% | -532.49% | -250.14% | -354.14% |
| Operating Income | -8.37M | -6.16M | -2.71M | -2.93M |
| Operating Income Ratio | -819.68% | -534.48% | -248.27% | -355.83% |
| Total Other Income/Expenses | -14.83M | 146.38K | -230.29K | 110.55K |
| Income Before Tax | -23.21M | -6.57M | -2.94M | -2.82M |
| Income Before Tax Ratio | -2,271.37% | -569.63% | -269.37% | -342.41% |
| Income Tax Expense | 0.00 | 356.49K | 160.47K | -193.55K |
| Net Income | -23.21M | -6.57M | -2.94M | -2.82M |
| Net Income Ratio | -2,271.37% | -569.63% | -269.37% | -342.41% |
| EPS | -4.77 | -1.36 | -0.61 | -0.58 |
| EPS Diluted | -4.77 | -0.20 | -0.09 | -0.09 |
| Weighted Avg Shares Out | 7.08M | 4.84M | 4.84M | 4.84M |
| Weighted Avg Shares Out (Dil) | 7.08M | 32.26M | 32.26M | 32.26M |
OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement
Partner's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies Partner's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies
OneMedNet Significantly Expands Industry Access to Proprietary iRWD™ Network and Platform by Joining AWS Partner Network
Secures new life science company customer through this globally recognized and trusted new channel Secures new life science company customer through this globally recognized and trusted new channel
Why Is OneMedNet (ONMD) Stock Up 150% Today?
Healthcare data management firm OneMedNet (NASDAQ: ONMD ) saw its shares skyrocket on Thursday, gaining over 150%. Management recently announced a greater than five-fold expansion of its proprietary data network.
OneMedNet Corporation Announces Participation in the EF Hutton Annual Global Conference
Minneapolis, Minnesota--(Newsfile Corp. - May 2, 2024) - OneMedNet Corporation (NASDAQ: ONMD), is the leading curator of precision curated regulatory-grade Real World Data (“RWD”), will be participating in the EF Hutton Annual Global Conference, which will take place on May...
OneMedNet Joins ClinEco Community of Clinical Research Industry Members
~ Validates OneMedNet's Regulatory Grade Real World Data Platform Among the Clinical Trial Eco-System ~ MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of precision curated regulatory-grade Real World Data (“RWD”), today announced...
OneMedNet Completes Securities Purchase Agreement, Solidifying Cash Position to Accelerate Growth
Cash Infusion Provides Significant Cash Runway of Up to $4.54 Million Cash Infusion Provides Significant Cash Runway of Up to $4.54 Million
OneMedNet Announces CEO Succession Plan
~ President, Aaron Green, Assumes Role of Chief Executive Officer ~ ~ CEO, Paul Casey, Announces Retirement and Shift to Active Advisory Role to Guide Transition Successfully ~ ~ Casey to Remain on Board Post-Transition ~ MINNEAPOLIS, April 02, 2024...
OneMedNet iRWD® Draws Attention at Clinical Trials Meeting
MINNEAPOLIS, Feb. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“iRWD”), is receiving an enthusiastic response from attendees at the 15th Annual SCOPE Summit.
OneMedNet Sees Real World Data Growth in Women's Health
MINNEAPOLIS, Feb. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“RWD”), today announced a growth initiative supporting women's health research. The company is seeing increasing business...
Why Is OneMedNet (ONMD) Stock Up 169% Today?
OneMedNet (NASDAQ: ONMD ) stock is taking off on Monday despite a lack of news from the health data sharing technology company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the...
Source: https://incomestatements.info
Category: Stock Reports